1. Home
  2. MXCT vs QSI Comparison

MXCT vs QSI Comparison

Compare MXCT & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • QSI
  • Stock Information
  • Founded
  • MXCT 1999
  • QSI 2013
  • Country
  • MXCT United States
  • QSI United States
  • Employees
  • MXCT N/A
  • QSI N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • QSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • MXCT Health Care
  • QSI Health Care
  • Exchange
  • MXCT Nasdaq
  • QSI Nasdaq
  • Market Cap
  • MXCT 242.4M
  • QSI 208.6M
  • IPO Year
  • MXCT 2021
  • QSI N/A
  • Fundamental
  • Price
  • MXCT $1.40
  • QSI $1.14
  • Analyst Decision
  • MXCT Buy
  • QSI Strong Buy
  • Analyst Count
  • MXCT 4
  • QSI 3
  • Target Price
  • MXCT $7.50
  • QSI $2.38
  • AVG Volume (30 Days)
  • MXCT 1.2M
  • QSI 6.7M
  • Earning Date
  • MXCT 08-06-2025
  • QSI 08-05-2025
  • Dividend Yield
  • MXCT N/A
  • QSI N/A
  • EPS Growth
  • MXCT N/A
  • QSI N/A
  • EPS
  • MXCT N/A
  • QSI N/A
  • Revenue
  • MXCT $35,754,000.00
  • QSI $3,412,000.00
  • Revenue This Year
  • MXCT N/A
  • QSI $45.62
  • Revenue Next Year
  • MXCT $14.79
  • QSI $218.03
  • P/E Ratio
  • MXCT N/A
  • QSI N/A
  • Revenue Growth
  • MXCT N/A
  • QSI 100.47
  • 52 Week Low
  • MXCT $1.26
  • QSI $0.61
  • 52 Week High
  • MXCT $5.20
  • QSI $5.77
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 31.00
  • QSI 36.61
  • Support Level
  • MXCT $1.37
  • QSI $0.95
  • Resistance Level
  • MXCT $1.48
  • QSI $1.14
  • Average True Range (ATR)
  • MXCT 0.09
  • QSI 0.08
  • MACD
  • MXCT 0.02
  • QSI 0.02
  • Stochastic Oscillator
  • MXCT 46.43
  • QSI 60.61

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

Share on Social Networks: